Acylcarnitine Profile After Intensive Care

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

November 3, 2021

Primary Completion Date

January 1, 2025

Study Completion Date

January 1, 2026

Conditions
Critical CareCarnitine Metabolism Disturbances
Interventions
DIAGNOSTIC_TEST

Serum acylcarnitine profiling

"Blood samples are collected through a central or peripheral venous line placed for clinical use, or through venous punction. Blood will be drawn into a serum gel tube (BD Vacutainer, Becton, Dickinson and Company, Franklin Lakes, NJ, USA), before being centrifuged (3500 rpm, 15 min, 4°C). Supernatant will be frozen at -20°C and stored for later analysis.~Serum ACs concentrations (free carnitine (C0), C2-, C3-, C3DC-, C4-, C4-OH-, C4-DC-, C5-, C5:1-, C5-OH-, C5DC-, C6-, C6-OH-, C6-DC-, C8-, C8:1-, C10-, C10:1-, C10:2-, C12-, C12:1-, C14-, C14:1-, C14:2-, C14-OH-, C16-, C16:1-, C16-OH-, C16-1-OH-, C17-, C18- ,C18:1-, C18:2-, C18-OH-, C18:1-OH-, C18:2-OH-carnitine) will be determined on a TQ5500 tandem mass spectrometer (Sciex, Framingham, MA, USA)."

Trial Locations (1)

4000

RECRUITING

University Hospital of Liège, Liège

All Listed Sponsors
lead

University of Liege

OTHER